• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺鳞癌切除病例的临床病理研究

A clinicopathologic study of resected cases of adenosquamous carcinoma of the lung.

作者信息

Shimizu J, Oda M, Hayashi Y, Nonomura A, Watanabe Y

机构信息

Department of Surgery, Kanazawa University School of Medicine, Japan.

出版信息

Chest. 1996 Apr;109(4):989-94. doi: 10.1378/chest.109.4.989.

DOI:10.1378/chest.109.4.989
PMID:8635382
Abstract

Adenosquamous carcinoma of the lung is an uncommon form of the lung cancer. Owing to the infrequent occurrence of this disease, no series reported to date (and to our knowledge) has been of adequate size for definitive statistical analysis. In this study, survival curves and background factors affecting prognosis in those with resected adenosquamous carcinoma of the lung were reviewed. In the period from 1973 to 1994, a total of 1,284 patients with primary lung cancer, including 44 cases (3.4%) of adenosquamous carcinoma, were surgically treated in our department. The cumulative 5-year postoperative survival rate, for all cases of adenosquamous carcinoma of the lung was 18.5%. When the survival rates were compared by histologic type, the outcomes of patients with adenosquamous carcinoma were statistically worse than for patients with squamous cell carcinoma and adenocarcinoma, owing to the highly aggressive pathologic stage of adenosquamous carcinoma. The background factors most closely associated with the survival rate in those with adenosquamous carcinoma, using Cox's proportional hazard model, were gender and the degree of nodal involvement. Five-year survival was obtained in seven patients as follows: T1N0M0 in one patient, T2N0M0 in three, T2N1M0 in two, and T3N0M0 in one. Of these seven patients, all had received complete resections, and five were N0 cases. Although our series is small, this study suggest that adenosquamous carcinoma of the lung is an aggressive tumor that grows rapidly.

摘要

肺腺鳞癌是肺癌的一种罕见形式。由于这种疾病发病率低,迄今为止(据我们所知)尚无足够规模的系列报道可供进行确定性的统计分析。在本研究中,我们回顾了肺腺鳞癌切除患者的生存曲线及影响预后的背景因素。1973年至1994年期间,我科共手术治疗了1284例原发性肺癌患者,其中包括44例(3.4%)肺腺鳞癌患者。肺腺鳞癌所有病例的累计5年术后生存率为18.5%。按组织学类型比较生存率时,由于肺腺鳞癌病理分期侵袭性高,腺鳞癌患者的预后在统计学上比鳞状细胞癌和腺癌患者更差。使用Cox比例风险模型分析,与肺腺鳞癌患者生存率密切相关的背景因素是性别和淋巴结受累程度。7例患者获得了5年生存,情况如下:1例为T1N0M0,3例为T2N0M0,2例为T2N1M0,1例为T3N0M0。这7例患者均接受了完整切除,其中5例为N0病例。尽管我们的系列病例数较少,但本研究表明肺腺鳞癌是一种生长迅速的侵袭性肿瘤。

相似文献

1
A clinicopathologic study of resected cases of adenosquamous carcinoma of the lung.肺腺鳞癌切除病例的临床病理研究
Chest. 1996 Apr;109(4):989-94. doi: 10.1378/chest.109.4.989.
2
A clinicopathologic study of the resected cases of adenosquamous carcinoma of the lung.肺腺鳞癌切除病例的临床病理研究
Oncol Rep. 1998 Jul-Aug;5(4):861-5. doi: 10.3892/or.5.4.861.
3
Adenosquamous carcinoma of the lung. Surgical results compared with squamous cell and adenocarcinoma.肺腺鳞癌。手术结果与鳞状细胞癌和腺癌的比较。
Scand Cardiovasc J. 1999;33(1):29-32. doi: 10.1080/14017439950142000.
4
Poor prognosis after lung resection for patients with adenosquamous carcinoma of the lung.肺腺鳞癌患者肺切除术后预后较差。
Ann Thorac Surg. 2003 Jun;75(6):1740-4. doi: 10.1016/s0003-4975(03)00022-5.
5
Prognosis and survival after radical resection of primary adenosquamous lung carcinoma.原发性腺鳞癌根治性切除术后的预后与生存情况
Eur J Cardiothorac Surg. 2005 Apr;27(4):686-92. doi: 10.1016/j.ejcts.2004.12.030.
6
Adenosquamous carcinoma of the lung: surgical results as compared with squamous cell and adenocarcinoma cases.肺的腺鳞癌:与鳞癌和腺癌病例的手术结果比较。
Eur J Cardiothorac Surg. 2012 Feb;41(2):357-61. doi: 10.1016/j.ejcts.2011.05.050. Epub 2011 Dec 12.
7
The adenosquamous lung carcinoma: clinical and pathological characteristics.腺鳞癌:临床及病理特征
J Cardiovasc Surg (Torino). 1994 Dec;35(6):543-7.
8
Adenosquamous and squamous carcinoma of the colon and upper rectum: a clinical and histopathologic study.结肠和直肠上段腺鳞癌及鳞癌:一项临床与组织病理学研究
Dis Colon Rectum. 2001 Mar;44(3):341-6. doi: 10.1007/BF02234730.
9
Squamous/adenosquamous carcinoma of the gallbladder: Analysis of 34 cases and comparison of clinicopathologic features and surgical outcomes with adenocarcinoma.胆囊鳞状/腺鳞癌:34例分析及与腺癌临床病理特征和手术结果的比较
J Surg Oncol. 2015 Nov;112(6):677-80. doi: 10.1002/jso.24065. Epub 2015 Oct 13.
10
An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.一项关于手术分期为IB期宫颈癌患者细胞类型的分析:妇科肿瘤学组研究
Gynecol Oncol. 1996 Dec;63(3):304-11. doi: 10.1006/gyno.1996.0327.

引用本文的文献

1
Case report: A patient with EGFR L861Q positive adenosquamous lung carcinoma transforming into large cell neuroendocrine cancer after treatment with Almonertinib.病例报告:一名表皮生长因子受体(EGFR)L861Q阳性腺鳞癌患者在接受阿美替尼治疗后转化为大细胞神经内分泌癌。
Front Oncol. 2025 Feb 18;15:1453066. doi: 10.3389/fonc.2025.1453066. eCollection 2025.
2
Integrative prognostic modeling for stage III lung adenosquamous carcinoma post-tumor resection: machine learning insights and web-based implementation.III期肺腺鳞癌肿瘤切除术后的综合预后模型:机器学习见解与基于网络的实现
Front Surg. 2024 Oct 22;11:1489040. doi: 10.3389/fsurg.2024.1489040. eCollection 2024.
3
Adenosquamous Carcinoma of the Lung: Survival, Radiologic Findings, PD-L1, and Driver Mutations.
肺腺鳞癌:生存情况、影像学表现、程序性死亡受体配体1(PD-L1)及驱动基因突变
J Clin Med. 2024 Sep 25;13(19):5711. doi: 10.3390/jcm13195711.
4
Hypercalcemia-Leukocytosis syndrome and adenosquamous lung carcinoma: An overlooked conjugation.高钙血症-白细胞增多综合征与肺腺鳞癌:一种被忽视的结合。
Oncol Res. 2022 Jul 13;29(2):81-85. doi: 10.32604/or.2022.023450. eCollection 2021.
5
Surgical Options for Resectable Lung Adenosquamous Carcinoma: A Propensity Score-Matched Analysis.可切除肺腺鳞癌的手术选择:一项倾向评分匹配分析
Front Oncol. 2022 Jul 1;12:878419. doi: 10.3389/fonc.2022.878419. eCollection 2022.
6
Prognostic factors of T2aN0M0 (T3-4cmN0M0, stage IB) non-small-cell lung cancer after surgery: Single-center real-world research.T2aN0M0(T3-4cmN0M0,IB 期)非小细胞肺癌术后的预后因素:单中心真实世界研究。
Thorac Cancer. 2021 Dec;12(24):3319-3326. doi: 10.1111/1759-7714.14204. Epub 2021 Nov 3.
7
Treatment for Patients With Early Stage Adenosquamous Lung Cancer.早期腺鳞癌肺癌患者的治疗
JTO Clin Res Rep. 2020 Mar 4;1(2):100021. doi: 10.1016/j.jtocrr.2020.100021. eCollection 2020 Jun.
8
A nomogram to predict prognosis of patients with lung adenosquamous carcinoma: a population-based study.预测肺腺鳞癌患者预后的列线图:一项基于人群的研究。
J Thorac Dis. 2020 May;12(5):2288-2303. doi: 10.21037/jtd.2020.03.115.
9
Adenocarcinomatous-predominant subtype associated with a better prognosis in adenosquamous lung carcinoma.富含腺癌成分的肺鳞腺癌亚型与更好的预后相关。
BMC Cancer. 2020 Jun 5;20(1):520. doi: 10.1186/s12885-020-06972-5.
10
Clinical Outcomes of Different Generations of EGFR Tyrosine Kinase Inhibitors in Advanced Lung Adenosquamous Carcinoma.不同代 EGFR 酪氨酸激酶抑制剂治疗晚期肺腺鳞癌的临床结局。
Mol Diagn Ther. 2019 Dec;23(6):773-779. doi: 10.1007/s40291-019-00425-x.